IPOs
– The company plans a second Phase III trial in the US for ADHD, drawing lessons from the previous Phase III trial. Alcobra...
Hi, what are you looking for?
– The company plans a second Phase III trial in the US for ADHD, drawing lessons from the previous Phase III trial. Alcobra...
Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that orphan drug designation has been...
Added to her stormy personal life and public embarrassments, Nigella Lawson’s “The Taste” is likely to flop in America like a failed souffle, according...
Israel’s NeuroDerm, which has developed a transdermal drug delivery system for the treatment of Parkinson’s disease, ended the year on a really high note...
Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, has completed the Design of...
Charlie Shrem, former Bitcoin Foundation board member and CEO of the now-defunct exchange BitInstant, has been sentenced to two years in prison for helping users of...
No methods currently exist for the early detection of Alzheimer’s disease, which affects one out of nine people over the age of 65. Now,...
“Antisémitox will finally heal your anti-Semitism, ” is the new campaign buzz of the European Jewish organization (OJE ) in the fight against anti-Semitism,...
– The agreement gives Medivation the license to develop and commercialize Curetech’s pidilizumab cancer treatment. – Medivation has decided to exercise the option...
Goggle has filed a lawsuit against the State of Mississippi. The suit comes in response to that state’s attempts to hold the company responsible...